High-yield points
- Rare: under 1% of meningiomas, with no female predominance .
- Distinctive features:
- intraventricular and spinal locations are more common;
- higher grade is more frequent;
- survival is still better than in adults .
- Think NF2 or prior radiation:
- neurofibromatosis in about 1 in 5 children with meningioma;
- radiation-induced meningiomas in about 10% of brain tumor survivors at 25 years .
- GTR is the strongest prognostic factor (relapse-free survival HR 0.16).
- Upfront radiotherapy: no proven benefit.
- Worse prognosis: NF2 and grade 3 .
- Molecular: NF2 and SMARCE1 dominate. Adult risk schemes do not predict outcome at age 21 or younger .
Landmark papers
- Individual-patient meta-analysis (Kotecha et al., Lancet Oncol 2011): 677 patients. GTR vs subtotal resection gave better relapse-free survival (HR 0.16) and overall survival (HR 0.21), and upfront radiotherapy gave no significant benefit .
Meningiomas are common in adults but rare in children, and they are not simply small adult meningiomas. In children:
- Sex: there is no female predominance.
- Location: spinal tumors are about three times as common as in adults, and intraventricular tumors are well represented (19% in one series) .
- Grade: higher-grade histology is more frequent.
- Associations: many are linked to NF2 or prior cranial radiation.
- Prognosis: gross total resection (GTR) is the strongest prognostic factor .
Epidemiology and features
- Frequency:
- SEER 2004–2012: 0.64% of meningiomas were in patients aged 0–21 (381 of 59,148) .
- SEER 2000–2021: 0.2–0.6% of meningiomas per year .
- How they differ from adult meningiomas :
- Sex: 1:1 male-to-female, with no female predominance.
- Spine: 13.1% spinal, about three times the adult rate.
- Grade: more borderline and malignant tumors than in adults.
- Survival: better overall survival than adults.
- Single-center series (47 children) :
- Neurofibromatosis: 21%.
- Location: 19% intraventricular.
- Grade and size: WHO grade 2–3 in 61.7%, with large tumors (mean 61 cm³).
- Treatment: GTR in 82.9% and adjuvant radiotherapy in 53.2%.
- Recurrence: 21.3% at a median of 41 months. A higher MIB-1 index predicted recurrence.
Predisposition
- NF2-related schwannomatosis :
- Hallmark: bilateral vestibular schwannomas.
- Other tumors: meningiomas, other schwannomas and ependymomas.
- Recognition in children: it is under-recognized. Skin tumors, ocular signs (retinal hamartoma, cataract) or a mononeuropathy such as facial palsy may come first.
- Practical rule: a child with a meningioma needs NF2 evaluation (see caveats).
- Prior cranial radiation :
- Screening study: MRI found secondary tumors, almost all meningiomas, in 8.2% of survivors of childhood brain tumors a mean of 23 years after diagnosis.
- Cumulative incidence: 10.2% at 25 years.
- Registry under-capture: cancer registries missed them.
- Molecular profile (293 tumors, ages 0–39) :
- Alterations: tumors in young patients carry NF2 and SMARCE1 alterations more often than adult tumors, the latter linked to clear cell histology (see caveats).
- Adult tools don't transfer: adult risk tools (WHO grade, methylation class, chr1p loss) failed to predict progression at age 21 or younger.
- The dominant predictor at that age: extent of resection.
Management
- Surgery is the treatment.
- Individual-patient meta-analysis (677 patients) :
- Effect of GTR vs. subtotal resection:
- better relapse-free survival (HR 0.16);
- better overall survival (HR 0.21).
- Upfront radiotherapy gave no significant benefit.
- Worse relapse-free survival:
- NF2 (HR 2.36);
- WHO grade 3 (HR 3.9 vs. grade 1).
- Grade 3 (anaplastic) tumors (74 children, patient-level review) :
- Resection: GTR achieved in 60%, more often for convexity tumors.
- Survival: GTR improved overall and progression-free survival.
- Adjuvant therapy: no independent benefit was shown.
- Practical approach (see caveats):
- Preoperative embolization for large, vascular skull base or convexity tumors in older children.
- Intraventricular tumors: reach them through a corridor that avoids eloquent cortex, and control the choroidal feeders early.
- Radiotherapy: reserve it for residual or recurrent higher-grade tumors.
- Follow-up: long-term MRI follow-up, because recurrence rises with time .
Related topics
- Neurofibromatosis: NF2-related schwannomatosis and meningioma.
- Skull and Skull Base Bone Tumors: other skull and skull base lesions.
References
- Kotecha RS, Pascoe EM, Rushing EJ, et al. Meningiomas in children and adolescents: a meta-analysis of individual patient data. Lancet Oncol 2011;12(13):1229–1239. doi:10.1016/S1470-2045(11)70275-370275-3). PMID 22094004. verified
- Dudley RWR, Torok MR, Randall S, et al. Pediatric versus adult meningioma: comparison of epidemiology, treatments, and outcomes using the Surveillance, Epidemiology, and End Results database. J Neurooncol 2018;137(3):621–629. doi:10.1007/s11060-018-2756-1. PMID 29520612. verified
- Qiu H, Balasubramanian K, O'Connor D, et al. WHO grade 3 pediatric meningioma: a systematic review of clinical features and patient-level analysis of prognostic factors. Childs Nerv Syst 2026;42(1). doi:10.1007/s00381-026-07385-8. PMID 42446740. verified
- Zhang R, Li S, Ren Y, et al. Clinical features and survival outcomes of pediatric meningioma patients: an integrative analysis based on the SEER database. J Neurol Surg A Cent Eur Neurosurg 2026;87(5):338–345. doi:10.1055/a-2846-3421. PMID 41974191. verified
- Joseph J, Ganesh S, Raju K. Pediatric meningiomas: clinicopathological spectrum, long-term outcomes, and recurrence predictors. Pediatr Neurosurg 2026 (online ahead of print):1–12. doi:10.1159/000551876. PMID 41973674. verified
- Evans DG. NF2-related schwannomatosis. In: Adam MP, et al., eds. GeneReviews®. Seattle (WA): University of Washington, Seattle; 1993–; updated 2023. PMID 20301380. verified
- Remes TM, Suo-Palosaari MH, Heikkilä VP, et al. Radiation-induced meningiomas after childhood brain tumor: a magnetic resonance imaging screening study. J Adolesc Young Adult Oncol 2019;8(5):593–601. doi:10.1089/jayao.2019.0010. PMID 31063432. verified
- Berghaus N, Tauziède-Espariat A, Hielscher T, et al. Distinct molecular subgroups in pediatric and young-onset meningiomas require age-adapted risk stratification. Nat Commun 2026;17(1). doi:10.1038/s41467-026-75357-2. PMID 42449117. verified
Verification (2026-11-17):
- Each reference's authors, title, journal, year, volume, pages, DOI and PMID were checked on PubMed. Numbers were checked against the PubMed abstracts.
- References 3, 5 and 8 are 2026 publications without full page or article numbers in PubMed.
- Reference 6 (GeneReviews) was checked against its PubMed/Europe PMC summary (2023-04-20).
Caveats:
- The following are standard practice, not drawn from the cited abstracts:
- the "NF2 evaluation for every child with meningioma" rule;
- the SMARCE1–clear cell link;
- embolization;
- intraventricular approach;
- radiotherapy choices.
- Most series are retrospective.
- The figure is an original schematic.